Display options
Share it on

Open Neuroimag J. 2011;5:57-64. doi: 10.2174/1874440001105010057. Epub 2011 Oct 28.

Smaller regional gray matter volume in homeless african american cocaine-dependent men: a preliminary report.

The open neuroimaging journal

Rosalyn E Weller, Luke E Stoeckel, Jesse B Milby, Mark Bolding, Donald B Twieg, Robert C Knowlton, Malcolm J Avison, Zhaohua Ding

Affiliations

  1. Department of Psychology, University of Alabama at Birmingham (UAB), Birmingham, AL, London.

PMID: 22135719 PMCID: PMC3227861 DOI: 10.2174/1874440001105010057

Abstract

Models of addiction include abnormalities in parts of the brain involving executive function/inhibitory control. Although previous studies have reported evidence of structural abnormalities in cocaine-dependent individuals, none have specifically targeted the homeless. The present preliminary study investigated brain structure in such an understudied group, homeless, crack-cocaine-dependent African American men (n = 9), comparing it to that in healthy controls (n = 8). Structural data were analyzed using voxel based morphometry (VBM) and a regions of interest (ROI) analysis. Homeless cocaine-dependent individuals had smaller gray matter volume in dorsolateral prefrontal cortex, anterior cingulate, the cerebellum, insula, and superior temporal gyrus. Most of these areas subserve executive function or inhibitory control. These results are similar to those found in most previous studies of non-homeless cocaine-dependent individuals. Reduced gray matter in executive function/inhibitory control regions of the brain in cocaine-dependent individuals may be a preexisting risk factor for the development of addiction and/or a consequence of drug abuse.

Keywords: Addiction; VBM; executive function; inhibitory control.

References

  1. Exp Brain Res. 2000 Jul;133(1):66-70 - PubMed
  2. Neuroimage. 2004 Jan;21(1):450-5 - PubMed
  3. Biol Psychiatry. 2009 Apr 15;65(8):710-3 - PubMed
  4. Neuropsychopharmacology. 2007 Oct;32(10):2229-37 - PubMed
  5. Biol Psychiatry. 2002 Jan 15;51(2):134-42 - PubMed
  6. Brain Res. 2006 Aug 11;1105(1):130-42 - PubMed
  7. Neuropsychologia. 2004;42(11):1447-58 - PubMed
  8. J Subst Abuse Treat. 2008 Mar;34(2):180-91 - PubMed
  9. Addiction. 2007 Apr;102 Suppl 1:33-43 - PubMed
  10. Eur J Radiol. 2011 Nov;80(2):395-9 - PubMed
  11. Neuropsychopharmacology. 2004 May;29(5):952-9 - PubMed
  12. Exp Clin Psychopharmacol. 2007 Apr;15(2):165-75 - PubMed
  13. Neuron. 2004 Nov 18;44(4):729-40 - PubMed
  14. J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1524-31 - PubMed
  15. Neuron. 2008 Oct 9;60(1):174-88 - PubMed
  16. J Neurosci. 2003 Aug 27;23(21):7839-43 - PubMed
  17. Biol Psychiatry. 1999 May 1;45(9):1203-11 - PubMed
  18. Neuroimage. 2003 Jul;19(3):1095-102 - PubMed
  19. Neuroimage. 2000 Jun;11(6 Pt 1):805-21 - PubMed
  20. J Neurosci. 2007 Jun 6;27(23):6212-8 - PubMed
  21. Am J Psychiatry. 2004 Feb;161(2):233-41 - PubMed
  22. Cereb Cortex. 2000 Mar;10(3):318-25 - PubMed
  23. Neuroimage. 2005 Apr 1;25(2):607-15 - PubMed
  24. Nat Neurosci. 2003 Feb;6(2):115-6 - PubMed
  25. Drug Alcohol Depend. 2002 May 1;66(3):265-73 - PubMed
  26. Neuropsychologia. 2001;39(4):376-89 - PubMed
  27. Nat Neurosci. 2004 Feb;7(2):189-95 - PubMed
  28. Drug Alcohol Depend. 2010 Oct 1;111(3):191-9 - PubMed
  29. Neuroimage. 2002 Jan;15(1):273-89 - PubMed
  30. J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):610-4 - PubMed
  31. Neuropsychopharmacology. 2000 Oct;23(4):468-73 - PubMed
  32. Science. 2007 Jan 26;315(5811):531-4 - PubMed
  33. Brain. 1998 Apr;121 ( Pt 4):561-79 - PubMed
  34. Neuropsychopharmacology. 2010 Jan;35(1):217-38 - PubMed
  35. J Neuroimaging. 2007 Apr;17(2):131-40 - PubMed
  36. J Cereb Blood Flow Metab. 2005 Jul;25(7):928-36 - PubMed
  37. Curr Neuropharmacol. 2006 Jan;4(1):17-31 - PubMed
  38. Neuroimage. 2003 Jul;19(3):1233-9 - PubMed
  39. Neuroimage. 2001 Jul;14(1 Pt 1):21-36 - PubMed
  40. Neurology. 1991 Jan;41(1):34-8 - PubMed
  41. Neuropsychopharmacology. 2006 Jun;31(6):1318-26 - PubMed
  42. J Neuropsychiatry Clin Neurosci. 2004 Fall;16(4):456-64 - PubMed
  43. Neurol Res. 1985 Mar;7(1):2-10 - PubMed
  44. J Urban Health. 2004 Dec;81(4):606-17 - PubMed
  45. Drug Alcohol Depend. 2001 Mar 1;62(1):49-56 - PubMed
  46. Am J Psychiatry. 2003 Nov;160(11):2038-45 - PubMed
  47. J Magn Reson Imaging. 2005 Jul;22(1):13-22 - PubMed
  48. J Int Neuropsychol Soc. 1998 Nov;4(6):559-65 - PubMed
  49. Trends Mol Med. 2006 Dec;12(12):559-66 - PubMed
  50. Biol Psychiatry. 2004 Nov 15;56(10):803-9 - PubMed
  51. Neuropsychol Rev. 2007 Sep;17(3):337-45 - PubMed
  52. Neuropsychologia. 1971 Mar;9(1):97-113 - PubMed
  53. J Cogn Neurosci. 2006 Mar;18(3):444-55 - PubMed
  54. Neuroimage. 2010 Feb 1;49(3):2536-43 - PubMed
  55. Am J Psychiatry. 2002 Oct;159(10):1642-52 - PubMed
  56. Drug Alcohol Depend. 2002 Sep 1;68(1):87-93 - PubMed
  57. Addiction. 2006 Dec;101(12):1760-70 - PubMed
  58. J Psychoactive Drugs. 2002 Jul-Sep;34(3):281-8 - PubMed
  59. Biol Psychiatry. 2006 Apr 15;59(8):702-6 - PubMed
  60. Trends Cogn Sci. 2009 Sep;13(9):372-80 - PubMed
  61. J Neurosci. 2004 Dec 8;24(49):11017-22 - PubMed
  62. Curr Opin Psychiatry. 2006 Jan;19(1):25-33 - PubMed
  63. Psychopharmacology (Berl). 1999 Oct;146(4):373-90 - PubMed
  64. Am J Public Health. 1990 Nov;80(11):1384-6 - PubMed
  65. Addict Biol. 2001 Sep;6(4):347-361 - PubMed
  66. Hum Brain Mapp. 2009 Nov;30(11):3719-35 - PubMed
  67. Neuroimage. 2003 Jul;19(3):1085-94 - PubMed
  68. Nat Rev Neurosci. 2002 Aug;3(8):655-66 - PubMed
  69. Neuroimage. 2011 Jun 1;56(3):1021-6 - PubMed
  70. Psychiatry Res. 2004 Jul 30;131(2):135-45 - PubMed
  71. Neuropsychopharmacology. 2008 Jul;33(8):1798-806 - PubMed
  72. Biol Psychiatry. 2009 Jan 15;65(2):160-4 - PubMed
  73. Psychopharmacology (Berl). 2007 Mar;190(4):517-30 - PubMed

Publication Types

Grant support